AI in Medicine News — 2026-11-09 (Mon) Daily News

Overview

Activity is spread across diagnostic imaging and signal studies, clinical decision support tools, and hospital and national-level deployment. A privacy incident at Weill Cornell Medicine and an analysis of FDA-cleared AI devices stand out on the safety and regulatory side. None of the headlines give performance figures or trial phases, so evidence levels below are limited to what the headlines state.

Diagnostics and imaging

- A systematic review evaluates explainable AI and the RDoC framework in Alzheimer's diagnosis. This is review-level evidence; no accuracy figure is given. (Bioengineer.org) - An AI model improves pediatric arrhythmia detection using custom ECG data. The headline gives no detection rate or validation setting. (Bioengineer.org) - Machine learning models analyze tabular clinical data to improve glaucoma detection. No performance figure or validation stage is given. (Bioengineer.org) - A piece asks "Can AI Fracture Detection Prevent Diagnostic Lawsuits?" The headline poses a question and reports no result. (OC Academy)

Clinical decision support

- Machine learning predicts diabetes risk in NAFLD patients. No performance figure or validation stage is given. (Bioengineer.org) - Machine learning is used to target procalcitonin testing. No outcome data are given in the headline. (The American Journal of Managed Care) - Mayo Clinic Platform launches an AI tool to streamline clinical decision-making. This is a product launch; no evaluation data are given. (TechTarget) - A Chinese Medical Journal article review explores AI-powered continuous glucose monitoring (CGM) data analysis in diabetes care. This is review-level evidence. (EurekAlert!) - A review details AI, robotics and language models in remote patient monitoring. This is review-level evidence. (Bioengineer.org) 【Generative AI in medical documentation and records】 No notable developments. 【Hospital operations and care delivery】 - Dimension NXG launches OJAS Forward Deployed Engineering to take hospital AI "From Pilot to Patient," six months ahead of India's data protection deadline. (The Tribune) - NUHS, Singtel and Ericsson expand their partnership on AI-enabled healthcare and 6G research. (BioPharma APAC) - The UK commits $120M to AI health hubs described as detecting disease years ahead; Garmin joins. The detection claim is the outlet's wording and no supporting data are given. (Tech Times) - Apollo says insurance and AI are key to India's medical tourism boom. (Rediff MoneyWiz) - Tencent Cloud Enterprise unveils a full-stack intelligent private cloud for sovereign agentic AI. The headline does not specify a healthcare use. (ACROFAN USA) 【Drug discovery and clinical trials】 No headline states a development stage (preclinical, Phase I or later). - QUANTRO Therapeutics secures an Austrian research grant to expand its AI-powered drug discovery platform. (Pulse 2.0) - GaiaBT links AI drug matching to lab validation to boost Korea oncology R&D. (Chosunbiz) - Tencent's AI chief says AI will soon master biology, unleashing new safety risks. (South China Morning Post) - AI, automation and novel assays accelerate the hunt for new medicines. (Bioengineer.org) 【Medical device approval and regulation】 - This is an analysis of already-cleared devices, not a new clearance, designation or guidance. One-third of 163 FDA-cleared AI medical devices got algorithm updates, but most reported no clinical benefit data. No product names are given. (Medical Daily)

Safety, errors and bias

- Weill Cornell says radiology patients' medical details were entered into AI tools without authorization. (inkl) - The headline is hedged and the case is unconfirmed. (Martin Cid Magazine) - The Tencent AI chief's warning about new safety risks as AI masters biology is noted under section 6. (South China Morning Post) 【Research results (major journals)】 No major-journal papers appear in the headlines. A Voice of Healthcare piece covers how AI and advanced imaging are reshaping radiology, but it is not a journal paper. (Voice of Healthcare)

Developments in Japan

- Shimane University begins joint research on medical MaaS in the Masuda area. It is introducing online-consultation vehicles in hilly and mountainous areas to evaluate the effect. No results are given. (Minna no Koho Senden-bu) - Two other Japanese headlines concern software security diagnosis or business use of AI, not medicine: Trust Inc.'s AI-based web application vulnerability diagnosis service (Excite), and an article on AI security (Business+IT). A further item reports survey results on AI use in teams and companies (Niconico News).

Statements by key figures

No notable developments.